402 related articles for article (PubMed ID: 31183682)
21. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
[TBL] [Abstract][Full Text] [Related]
23. SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
Wang Y; Cao R; Yang W; Qi B
J Cell Physiol; 2019 Aug; 234(8):14319-14329. PubMed ID: 30652310
[TBL] [Abstract][Full Text] [Related]
24. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
25. LncRNA TINCR improves cardiac hypertrophy by regulating the miR-211-3p-VEGFB-SDF-1α-CXCR4 pathway.
Tu S; Wang XY; Zeng LX; Shen ZJ; Zhang ZH
Lab Invest; 2022 Mar; 102(3):253-262. PubMed ID: 34732848
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
Li D; Shen M; Deng X; Bai Y
Bioengineered; 2022 Apr; 13(4):8982-8993. PubMed ID: 35348441
[TBL] [Abstract][Full Text] [Related]
27. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
28. LncRNA PEAMIR inhibits apoptosis and inflammatory response in PM2.5 exposure aggravated myocardial ischemia/reperfusion injury as a competing endogenous RNA of miR-29b-3p.
Pei YH; Chen J; Wu X; He Y; Qin W; He SY; Chang N; Jiang H; Zhou J; Yu P; Shi HB; Chen XH
Nanotoxicology; 2020 Jun; 14(5):638-653. PubMed ID: 32100595
[TBL] [Abstract][Full Text] [Related]
29. LncRNA TUG1 Contributes to Hypoxia-Induced Myocardial Cell Injury Through Downregulating miR-29a-3p in AC16 Cells.
Song T; Wang P; Xin L
J Cardiovasc Pharmacol; 2020 Nov; 76(5):533-539. PubMed ID: 33165134
[TBL] [Abstract][Full Text] [Related]
30. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
Jia G; Liang C; Li W; Dai H
Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression.
Liu J; Wu D; Lin X; Hong Y; Wang X; Zheng C; Wu Z; Hong Y; Lv Y
Life Sci; 2021 Feb; 267():118902. PubMed ID: 33340525
[TBL] [Abstract][Full Text] [Related]
32. lncRNA TUG1 promotes proliferation and differentiation of osteoblasts by regulating the miR-545-3p/CNR2 axis.
Hao R; Wang B; Wang H; Huo Y; Lu Y
Braz J Med Biol Res; 2020; 53(11):e9798. PubMed ID: 33053117
[TBL] [Abstract][Full Text] [Related]
33. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
[TBL] [Abstract][Full Text] [Related]
34. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
Zhang X; Yang L; Xu G
Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
[TBL] [Abstract][Full Text] [Related]
35. LncRNA TUG1 acts as a competing endogenous RNA to mediate CTGF expression by sponging miR-133b in myocardial fibrosis after myocardial infarction.
Zhang S; Wang N; Ma Q; Fan F; Ma X
Cell Biol Int; 2021 Dec; 45(12):2534-2543. PubMed ID: 34553456
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR-182-5p/IGF1 axis.
Wang D; Lin B; Zhang W; Wang X
Cell Biol Int; 2020 Jul; 44(7):1426-1435. PubMed ID: 32125046
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of TUG1 rescues cardiomyocyte hypertrophy through targeting the miR-497/MEF2C axis.
Zhang G; Ni X
Open Life Sci; 2021; 16(1):242-251. PubMed ID: 33817315
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.
Su Q; Liu Y; Lv XW; Dai RX; Yang XH; Kong BH
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H332-H344. PubMed ID: 31858814
[TBL] [Abstract][Full Text] [Related]
39. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway.
Zhang M; Jiang Y; Guo X; Zhang B; Wu J; Sun J; Liang H; Shan H; Zhang Y; Liu J; Wang Y; Wang L; Zhang R; Yang B; Xu C
J Cell Mol Med; 2019 Nov; 23(11):7685-7698. PubMed ID: 31465630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
